Retraction notice to "Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221" [Eur. J. Pharmacol. 853 (2019) 353-363]

Zhou Cheng; Dayuan Xing

doi:10.1016/j.ejphar.2022.175123

Retraction notice to "Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221" [Eur. J. Pharmacol. 853 (2019) 353-363]

Eur J Pharmacol. 2022 Aug 5:928:175123. doi: 10.1016/j.ejphar.2022.175123. Epub 2022 Jul 5.

Authors

Zhou Cheng¹, Dayuan Xing²

Affiliations

¹ Department of Stomatology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, China. Electronic address: chengzhou213@sina.com.
² Department of Stomatology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, China.

PMID: 35803779
DOI: 10.1016/j.ejphar.2022.175123

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Given the comments regarding this article https://pubpeer.com/publications/917A4D8593F06C8E5ADC7AA0A30136, particularly regarding the background of the Western Blots from Figure 2B, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.

Publication types

Retraction of Publication